These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34326320)
1. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth. Zhou T; Sang YH; Cai S; Xu C; Shi MH Cell Death Dis; 2021 Jul; 12(8):751. PubMed ID: 34326320 [TBL] [Abstract][Full Text] [Related]
2. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer. Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734 [TBL] [Abstract][Full Text] [Related]
3. Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth. Wang H; Liu Y; Lu XS; Wu Y; Gu W; Yin G Cell Death Dis; 2024 Sep; 15(9):643. PubMed ID: 39227564 [TBL] [Abstract][Full Text] [Related]
4. Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma. Han QC; Zhang XY; Yan PH; Chen SF; Liu FF; Zhu YR; Tian Q Cell Death Discov; 2021 Dec; 7(1):393. PubMed ID: 34907167 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells. Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343 [TBL] [Abstract][Full Text] [Related]
7. Expression of HAb18G in non-small lung cancer and characterization of activation, migration, proliferation, and apoptosis in A549 cells following siRNA-induced downregulation of HAb18G. Xu X; Liu S; Lei B; Li W; Lin N; Sheng W; Huang A; Shen H Mol Cell Biochem; 2013 Nov; 383(1-2):1-11. PubMed ID: 24013786 [TBL] [Abstract][Full Text] [Related]
8. The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth. Wang Y; Ou L; Li X; Zheng T; Zhu WP; Li P; Wu L; Zhao T Cell Death Discov; 2022 Aug; 8(1):347. PubMed ID: 35922422 [TBL] [Abstract][Full Text] [Related]
9. CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145. Yang H; Zhao M; Zhao L; Li P; Duan Y; Li G Cell Oncol (Dordr); 2020 Jun; 43(3):477-488. PubMed ID: 32297303 [TBL] [Abstract][Full Text] [Related]
10. Elevated origin recognition complex subunit 6 expression promotes non-small cell lung cancer cell growth. Sang YH; Luo CY; Huang BT; Wu S; Shu J; Lan CG; Zhang F Cell Death Dis; 2024 Sep; 15(9):700. PubMed ID: 39349930 [TBL] [Abstract][Full Text] [Related]
11. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth. Li SP; Ou L; Zhang Y; Shen FR; Chen YG Cell Death Dis; 2023 Feb; 14(2):152. PubMed ID: 36823110 [TBL] [Abstract][Full Text] [Related]
12. Identification of the central role of RNA polymerase mitochondrial for angiogenesis. Huan MJ; Fu PP; Chen X; Wang ZX; Ma ZR; Cai SZ; Jiang Q; Wang Q Cell Commun Signal; 2024 Jun; 22(1):343. PubMed ID: 38907279 [TBL] [Abstract][Full Text] [Related]
13. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo. Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583 [TBL] [Abstract][Full Text] [Related]
14. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo. Zhang K; Li Y; Liu W; Gao X; Zhang K Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812 [TBL] [Abstract][Full Text] [Related]
15. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy. Ma J; Wu K; Liu K; Miao R Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated Sui J; Zhao Q; Zhang Y; Liang G DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469 [TBL] [Abstract][Full Text] [Related]
17. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094 [No Abstract] [Full Text] [Related]
18. Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Paleari L; Catassi A; Ciarlo M; Cavalieri Z; Bruzzo C; Servent D; Cesario A; Chessa L; Cilli M; Piccardi F; Granone P; Russo P Cell Prolif; 2008 Dec; 41(6):936-59. PubMed ID: 19040571 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression. Zheng J; Zhang Y; Cai S; Dong L; Hu X; Chen MB; Zhu YH Cancer Lett; 2020 Apr; 476():129-139. PubMed ID: 32081805 [TBL] [Abstract][Full Text] [Related]
20. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth. Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]